News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: ststephensrevenge post# 260123

Monday, 03/28/2016 10:16:40 PM

Monday, March 28, 2016 10:16:40 PM

Post# of 347009

The primary directive of the FDA is:

Protect BP profits....period end of story.

Anyone who fails to grasp this corrupt reality is sadly mistaken.



Protecting BP profit days are gone. Enter the days of immunotherapy.

Now you know why some decided it was a chance that had to be taken: to sabotage Peregrine trials and slow them the hell down

Any other small biotech would have folded and given up to the BP powers

Peregrine Pharmaceuticals still standing, which is why a boat load of posters still here

Hopefully all are loaded up on shares on PPHM because in Time the story unfolds perfectly for PS Targeting

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y